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Epithelial-to-mesenchymal transition (EMT) confers
several traits to cancer cells that are required for
malignant progression. Here, we report that miR-
27b-3p-mediated silencing of the single-strand
RNA binding protein KHSRP is required for trans-
forming growth factor b (TGF-b)-induced EMT in
mammary gland cells. Sustained KHSRP expres-
sion limits TGF-b-dependent induction of EMT fac-
tors and cell migration, whereas its knockdown
in untreated cells mimics TGF-b-induced EMT.
Genome-wide sequencing analyses revealed that
KHSRP controls (1) levels of mature miR-192-5p,
a microRNA that targets a group of EMT factors,
and (2) alternative splicing of a cohort of pre-
mRNAs related to cell adhesion and motility
including Cd44 and Fgfr2. KHSRP belongs to a
ribonucleoprotein complex that includes hnRNPA1,
and the two proteins cooperate in promoting
epithelial-type exon usage of select pre-mRNAs.
Thus, TGF-b-induced KHSRP silencing is central
in a pathway leading to gene-expression changes
that contribute to the cellular changes linked
to EMT.INTRODUCTION
Epithelial-to-mesenchymal transition (EMT) is a reversible trans-
differentiation process in which epithelial cells lose their charac-
teristics and instead acquire mesenchymal properties. EMT
has been implicated in several physiological and pathologicalThis is an open access article under the CC BY-Nprocesses, including embryonic development, wound healing,
organ fibrosis, and cancer progression (see Kalluri andWeinberg
[2009] for a review).
Through EMT, cells gain the ability to migrate and resist
apoptosis as well as the potential to enter stem cell-like states
(De Craene and Berx, 2013; Ye and Weinberg, 2015). Phenotyp-
ical hallmarks of EMT include morphological changes from a
cobblestone-like epithelial shape to a spindle-like fibroblast
phenotype, loss of epithelial CDH1 (also known as E-cadherin)
at cell junctions, and increased expression of mesenchymal
CDH2 (also known asN-cadherin). The opposite transdifferentia-
tion process, mesenchymal-to-epithelial transition (MET), is also
possible (De Craene and Berx, 2013; Ye and Weinberg, 2015).
For many years, it has been proposed that cancer cells undergo
EMT to facilitate invasion and dissemination although recent ev-
idence proposed that EMT is instead a prerequisite for acquisi-
tion of chemoresistance (Fischer et al., 2015; Zheng et al., 2015).
EMT is initiated by signals that cells receive from their micro-
environment, and transforming growth factor b (TGF-b) is
considered to act as a primary inducer of this process (Mousta-
kas and Heldin, 2012; Katsuno et al., 2013). TGF-b belongs to
a large family of structurally related factors, including activins
and bone morphogenetic proteins (BMPs), which regulate cell
growth, survival, differentiation, and migration (Shi and Mas-
sague´, 2003). TGF-b ligands signal through receptor serine/thre-
onine kinases that, in turn, phosphorylate cell-specific SMAD
proteins that form complexes with the common SMAD4, translo-
cate into the nucleus and regulate gene expression by modu-
lating gene transcription as well as by promoting maturation of
select microRNAs (miRNAs) from precursors (Blahna and Hata,
2012).
Recently, we have demonstrated that the single-strand RNA-
binding protein KHSRP (also known as KSRP) is a component
of the TGF-b/BMP signaling pathway in multipotent C2C12 cells.
TGF-b/BMP-activated SMAD proteins associate with KHSRPCell Reports 16, 967–978, July 26, 2016 ª 2016 The Author(s). 967
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. KHSRP Silencing during TGF-
b-Induced EMT in NMuMg Cells
(A) Left: qRT-PCR analysis of Khsrp in NMuMg
cells serum-starved (2% FBS, 16 hr) and either
treated with TGF-b (10 ng/ml) for the indicated
times or untreated (time 0). Right: immunoblot
analysis of total cell extracts from NMuMg cells
serum-starved and either treated with TGF-b (+)
for the indicated times or untreated (). The indi-
cated antibodies were used.
(B) Immunoblot analysis of total cell extracts
from NMuMg cells untreated (lane 1), treated with
TGF-b for 7 days (lane 2), or treated with TGF-b for
7 days and then cultured in normal growthmedium
for 5 days (lane 3). The indicated antibodies were
used.
(C) qRT-PCR analysis of nascent Khsrp transcript
(Click-iT, see the Experimental Procedures) in
NMuMg cells either untreated () or treated with
TGF-b for 24 hr (+).
(D) qRT-PCR analysis of miR-27b-3p in NMuMg
cells either untreated or treated with TGF-b for
the indicated times.
(E) Immunoblot analysis of total cell extracts from
either control- (mimic-miR-C) or mimic-miR-27b-
3p- transfected NMuMg cells. The indicated anti-
bodies were used.
The position of molecular mass markers is indi-
cated on the left of each immunoblot. Representative gels are shown. The values of qRT-PCR experiments shown are averages ± SEM of three independent
experiments performed in triplicate. Statistical significance: *p < 0.01, **p < 0.001 (Student’s t test).
See also Figure S1.and block its ability to promote maturation of myogenic miRNAs
from precursors, thus orienting C2C12 cells toward osteoblastic
differentiation. Accordingly, KHSRP silencing in C2C12 cells
produces effects that largely coincide with those induced by
TGF-b/BMP signaling activation (Pasero et al., 2012). Further, it
has been recently reported that TGF-b regulates wound healing
by controlling KHSRP levels and determining a switch between
miR-198 and Follistatin-like 1 (FSTL1) protein expression (Sun-
daram et al., 2013). In general, KHSRP can be viewed as a
multifunctional and versatile regulator of post-transcriptional
switches that operates as a flexible effector of dynamic changes
during transdifferentiation processes.
For these reasons, we decided to investigate KHSRP role in
TGF-b-dependent EMT and provide evidence that miRNA-medi-
ated KHSRP silencing is required for TGF-b-induced EMT in
mammary gland cells. KHSRP is a crucial factor in maintaining
the epithelial phenotype by promoting maturation of miR-192-
5p from precursors and favoring the epithelial-type splicing
pattern of a group of pre-mRNAs including Cd44 and Fgfr2.
RESULTS
KHSRP Is Silenced during TGF-b-Induced Epithelial-to-
Mesenchymal Transition in Mammary Gland Cells
In order to investigate whether KHSRP is implicated in TGF-
b-induced EMT, we adopted the murine immortalized mam-
mary epithelial cell line NMuMg as a model. These cells
acquire mesenchymal traits and display the gene expression
pattern typical of EMT in response to TGF-b (Avery-Cooper
et al. [2014] and references cited therein) (Figures S1A–968 Cell Reports 16, 967–978, July 26, 2016S1C). Importantly, KHSRP expression was silenced in a
time-dependent manner in response to TGF-b (Figure 1A)
and its levels were restored when TGF-b was removed from
cultures (Figure 1B). qRT-PCR analysis of nascent transcripts
showed that TGF-b produces a limited change in Khsrp
transcription (Figure 1C) thus prompting us to investigate a
post-transcriptional mechanism for TGF-b-dependent KHSRP
silencing. Genome-wide deep RNA-sequencing (RNA-seq)
analysis performed on the small RNA population (see below)
revealed that two miRNAs (miR-27b-3p and miR-181a), previ-
ously reported to target KHSRP (Zhou et al., 2012; Sundaram
et al., 2013), are induced by TGF-b in NMuMg cells with
timing compatible with KHSRP downregulation (Figures 1D
and S1D). miR-27b-3p transfection caused KHSRP downre-
gulation in untreated NMuMg cells while miR-181a did not
produce any effect (Figures 1E, S1E, and S1F). Furthermore,
miR-27b-3p silencing prevented TGF-b-induced Khsrp down-
regulation (Figure S1G).
The observation that TGF-b causes KHSRP silencing was
extended to other mammary epithelial cell lines known to un-
dergo EMT in response to the cytokine treatment (human non-
tumorigenic MCF 10A and human mammary epithelial (HMLE)
cells as well as murine Py2T cells, Figure S1H). Conversely,
TGF-b did not reduce KHSRP expression in breast cancer cell
lines that display a limited EMT response to TGF-b such as
MDA-MB-231, 4T1, TS/A, HMLER, and MCF7 (Figure S1I; data
not shown).
Altogether, these results indicate that KHSRP is silenced by
miR-27b-3p in mammary gland cell lines that undergo EMT in
response to TGF-b.
Figure 2. Forced KHSRP Expression Pre-
vents TGF-b-Induced EMT and Reprograms
the Transcriptome of NMuMg Cells
(A) qRT-PCR analysis of the indicated tran-
scripts in NMuMg cells infected with either con-
trol (AdNull) or KHSRP-expressing (AdKHSRP)
adenoviral vectors for 24 hr and subsequently
serum-starved and either treated with TGF-b (+)
for 24 hr or untreated ().
(B) Immunoblot analysis of total cell extracts from
cells treated as in (A). The indicated antibodies
were used. The position of molecular mass
markers is indicated on the left. Representative
gels are shown.
(C) Gene Ontology (GO) analysis. RNA isolated
from either AdNull- or AdKHSRP-expressing and
TGF-b-treated NMuMg cells was subjected to
RNA-seq analysis. Genes showing a log2-fold
change >1.5 in the biological triplicates were used
for GO analysis, and the enrichment of the
KHSRP-regulated pathways are presented as pie
graph.
(D) qRT-PCR analysis of the indicated transcripts
in cells treated as in (A).
(E) Scratch wound healing assay. NMuMg cells
were cultured as in (A) and scratch wounds were
introduced into confluent monolayers. Cultures
were photographed and the width of the wound
was measured at 0 hr and 48 hr after the scratch
was made. The percentage of the wound healed
area for each culture condition was plotted
(top right bar graph). Representative images are
shown. Scale bars represent 100 mm.
(F) qRT-PCR analysis of the indicated transcripts
in NMuMg cells transfected with either control
anti-miRNA (anti-miR-C) or anti-miR-27b-3p and
subsequently serum-starved and either treated
with TGF-b (+) for 36 hr or untreated ().
The values of qRT-PCR experiments shown are
averages (±SEM) of three independent experi-
ments performed in triplicate. Statistical signifi-
cance: *p < 0.005, **p < 0.001 (Student’s t test).
See also Figure S2 and Table S1.Forced KHSRP Expression Prevents TGF-b-Induced
EMT and Reprograms the Transcriptome of NMuMg
Cells
We investigated whether KHSRP downregulation is required for
TGF-b-induced EMT. To this purpose, we transiently overex-
pressed KHSRP (AdKHSRP) in NMuMg cells—in order to main-
tain its constant levels during TGF-b treatment—and analyzed
the expression of some factors known as hallmarks of EMT in-
duction (Figure S2A). As shown in Figures 2A and 2B, KHSRP
overexpression significantly impaired the TGF-b-dependent
induction of Snai1, Fn1 (a.k.a. fibronectin), and CDH2 (a.k.a.
N-cadherin) when compared to control (AdNull) cells. Next,
we performed RNA-seq analyses to investigate the changes
induced in the whole transcriptome by sustained KHSRP
expression. Gene Ontology enrichment (GO) analysis revealed
that KHSRP-regulated transcripts were involved in cell adhe-
sion, cell motility/migration, and cytokine/receptor interaction(Figure 2C). Our qRT-PCR-based validation of RNA-seq data
showed that KHSRP overexpression counteracts the TGF-
b-dependent induction of transcripts relevant to collagen meta-
bolism (e.g.,Col12a1,Col6a2), cell adhesion (e.g., Iglon5), TGF-b
signaling (e.g., Fstl1), extracellular matrix organization (e.g.,
Adamtsl2, Gpc6, Wisp2), cytokine-receptor interaction (Ccl17),
and glycosaminoglycan metabolism (e.g., Chst1) (Figures 2D
and S2B; Table S1). Consistently, scratch wound assays re-
vealed that KHSRP overexpression in TGF-b-treated cells re-
duces the wound closure when compared to negative control
cells (Figure 2E). Finally, miR-27b-3p downregulation—similar
to KHSRP overexpression—prevented TGF-b-dependent induc-
tion of Snai1, Fn1, Cdh2, Zeb1, and Zeb2 gene expression (Fig-
ures 2F and S2C; Table S1).
Together, our results indicate that KHSRP-sustained expres-
sion impairs the TGF-b-dependent induction of factors related
to cell adhesion and motility and suggests that TGF-b-inducedCell Reports 16, 967–978, July 26, 2016 969
Figure 3. KHSRP Knockdown Mimics the
Phenotype of TGF-b-Induced EMT
(A) qRT-PCR analysis of the indicated transcripts
in either mock or shKHSRP untreated NMuMg
cells (upper panels) and in either control miRNA
mimic (mimic-miR-C) or mimic-miR-27b-3p (lower
panels)-transfected NMuMg cells.
(B) Scratch wound healing assay. Either mock or
shKHSRP NMuMg cells were serum-starved and
then either treated with TGF-b or untreated.
Scratch wounds were introduced into confluent
monolayers. Cultures were photographed and the
width of the wound was measured at 48 hr after
the scratch was made. The percentage of the
wound healed area for each culture condition was
plotted (top right bar graph). Representative im-
ages are shown. Scale bars represent 100 mm.
(C) Either mock or shKHSRP NMuMg cells were
serum-starved and then either treated with TGF-b
or untreated for 48 hr. Cells were stained using
Alexa Fluor 568 Phalloidin to visualize the actin
cytoskeleton. Representative images are shown.
Scale bars represent 50 mm.
(D) Left: schematic of the NMuMg cell treatment.
Right: qRT-PCR analysis of the indicated tran-
scripts in cells treated as summarized in the left
panel.
The values of qRT-PCR experiments shown are
averages ± SEM of three independent experi-
ments performed in triplicate. Statistical signifi-
cance: *p < 0.01, **p < 0.001 (Student’s t test). See
also Figure S3 and Table S1.KHSRP silencing is required to enable NMuMg cells to acquire
migratory properties.
KHSRP Knockdown Mimics the Phenotype of TGF-
b-Induced EMT
In order to unambiguously establish the role of KHSRP
silencing as a key step in TGF-b-induced EMT, we stably
knocked-down KHSRP (shKHSRP) in NMuMg cells (Figure S3A)
and found that shKHSRP mimics the effect of TGF-b on the
expression of EMT-related factors (Figures 3A, top panels,
and S3B; Table S1). Further, Figure 3A (bottom panels) and
Table S1 show that forced miR-27b-3p expression, similar970 Cell Reports 16, 967–978, July 26, 2016to KHSRP knockdown, induced expres-
sion of critical EMT factors.
Scratch wound assays showed that
KHSRP knockdown accelerates the
wound closure in both control and
TGF-b-treated cells (Figure 3B), and
the enhanced migratory potential of
shKHSRP cells was confirmed by trans-
well migration assays (Figure S3C). Ac-
cording to a recent report (Yao et al.,
2016), transient miR-27b-3p overexpres-
sion in NMuMg cells caused the appear-
ance of increased migration areas in
scratch wound assays (Figure S3D).
KHSRP downregulation also mimickedthe TGF-b-mediated remodeling of the cytoskeleton from
cortical actin to stress fibers as determined by phalloidin staining
(Figure 3C). Stable KHSRP knockdown mimicked the changes
induced by TGF-b also in Py2T cells (Figures S3E and S3F;
data not shown). Consistently, KHSRP overexpression impaired
the wound healing in Py2T cells while its downregulation
enhanced the gap closure (Figure S3G; data not shown).
Transient KHSRP re-expression reverted the EMT-like pheno-
type of shKHSRP NMuMg cells (Figures S3H and S3I). Most
importantly, we showed that cells that achieved an estab-
lished mesenchymal phenotype through a prolonged treatment
with TGF-b reacquire an epithelial phenotype upon KHSRP
Figure 4. KHSRP-Dependent Maturation
of miR-192-5p Prevents the Expression of
Some EMT Factors
(A) qRT-PCR analysis of the indicated miRNAs
or their primary transcripts in either mock or
shKHSRP NMuMg cells.
(B) qRT-PCR analysis of the indicated miRNAs in
serum-starved NMuMg cells either untreated or
treated with TGF-b for the indicated times.
(C) qRT-PCR analysis of the indicated transcripts
in NMuMg cells transfected with either miRNA in-
hibitor negative control or with miRCURY LNA
miR-192-5p inhibitor.
The values of qRT-PCR experiments shown are
averages ± SEM of three independent experi-
ments performed in triplicate. Statistical signifi-
cance: *p < 0.01, **p < 0.001 (Student’s t test). See
also Figure S4 and Table S1.re-expression and despite the continuous presence of TGF-b
(Figure 3D).
As a whole, these data indicate that KHSRP knockdown in
untreated cells induces phenotypic changes that mimic TGF-
b-induced EMT thus supporting our hypothesis that KHSRP
silencing is a required event for EMT occurring in response to
TGF-b.
KHSRP-Dependent Maturation of miR-192-5p Prevents
the Expression of Some EMT Factors
Cellular and animal experimental models have demonstrated
that KHSRP favors mRNA decay and miRNAmaturation in an in-
tegratedway (reviewed in Briata et al., 2016). Here, we found that
KHSRP is almost exclusively located in the nucleus of mammary
gland cells (Figures S4A and S4B; data not shown). In agreementCwith this observation, KHSRP silencing
did not affect the decay rate of several
mRNAs whose expression was signifi-
cantly increased upon either TGF-
b-induced EMT or KHSRP silencing
(Figure S4C; data not shown).
To explore the role of KHSRP in TGF-
b-controlled miRNA maturation, we
performedmiRNAdeep-sequencing ana-
lyses in shKHSRP NMuMg cells as
well as in control mock-transfected
cells. Bioinformatic analysis revealed
that KHSRP knockdown significantly re-
duces the expression of a limited number
of miRNAs (33 with p value <103 using
ANOVA test). qRT-PCR analysis revealed
that KHSRP knockdown reduces the
expression of miR-192-5p and miR-194-
5p without affecting the levels of the cor-
responding primary transcripts and this
indicates that KHSRP is required for the
maturation of these miRNAs (Figures 4A
and S4D; data not shown). Interestingly,
the levels of miR-192-5p and miR-194-5p were downregulated in the course of TGF-b-induced EMT
(Figure 4B). These observations, and the evidence that the
expression of miR-192-5p and miR-194-5p inversely correlates
with the metastatic potential of different cancer cells (Kim
et al., 2011; Geng et al., 2014; Dong et al., 2011; Le et al.,
2012), prompted us to investigate whether miR-192-5p and
miR-194-5p silencing recapitulates gene expression changes
induced by KHSRP silencing. Expression of anti-miR-192-5p in
NMuMg cells upregulated Zeb1, Zeb2, as well as Snai1, Iglon5,
and Mmp9 expression while it did not affect Fstl1 mRNA levels
and even caused downregulation of Fn1, Col6a2, and Col12a1
(Figure 4C; Table S1). Conversely, expression of anti-miR-194-
5p did not affect the expression of EMT factors whose levels
are regulated by KHSRP knockdown with the exception of a
moderate increase in Mmp9 expression (Figure S4E; Table S1).ell Reports 16, 967–978, July 26, 2016 971
In addition, the simultaneous silencing of the two miRNAs pro-
duced gene expression changes overlapping those caused by
miR-192-5p silencing (data not shown).
In conclusion, becausemiR-192-5p andmiR-194-5p silencing
failed to reproduce the whole spectrum of gene expression
changes induced by KHSRP downregulation, we hypothesized
that KHSRP silencing during TGF-b-induced EMT impacts on
an additional layer of post-transcriptional gene regulation.
KHSRP Controls Alternative Splicing of a Cohort of Pre-
mRNAs Involved in Cell Adhesion and Migration
To investigate whether KHSRP affects pre-mRNA splicing in
NMuMg cells, we applied a sensitive bioinformatic approach
to detect genes subject to differential exon usage (DEXSeq)
(Anders et al., 2012). In our RNA-seq data, we identified 763
alternative splicing events (log2 fold changes (FC) > j1.2j, BH
(Bonferroni-corected, two-sided hypergeometric test) adjusted
p value (adj.pval) < 0.01) involving 518 unique Ensembl tran-
scripts that were controlled by KHSRP overexpression (Table
S2). Among the regulated single cassette exons, 412 were less
included while 351 were more included upon KHSRP overex-
pression, a ratio similar to that recently reported for other RNA
binding proteins (RBPs) in a genome-wide analysis of alternative
splicing (Huelga et al., 2012). Our findings are in line with recent
evidence suggesting that modulation of alternative mRNA
splicing plays a causative role in EMT (Cieply and Carstens,
2015) and with the original observation from the Black laboratory
that KHSRP participates in alternative splicing (Min et al., 1997).
GO enrichment analysis revealed that mRNAs whose splicing is
affected by KHSRP overexpression are involved in biological
processes such as cytoskeleton organization, cell junction as-
sembly, and regulation of small GTPase-mediated signal trans-
duction (Figure S5A).
Among these transcripts, we validated some of the KHSRP-
controlled cassettes utilizing exon-specific primers by qRT-
PCR and focused exclusively on exons that have been proven
to generate alternative protein isoforms (according to the En-
sembl annotation GRCm38.74; http://www.ensembl.org/). Fig-
ures 5A and S5B show some representative examples, including
Enah, whose alternative splicing has been previously implicated
in EMT (Warzecha et al., 2009).
Interestingly, ribonucleoprotein immunoprecipitation (RIP) anal-
ysis followedbyRNAdeep-sequencingperformed inNMuMgcells
(P.B. and R.G, unpublished data) revealed that KHSRP interacts
with a number of pre-mRNAs including those encoding CD44
and FGFR2 (Warzecha et al., 2009; Brown et al., 2011) (Fig-
ure S5C; data not shown). It has been previously demonstrated
that TGF-b treatment induces a shift from the epithelial forms
of CD44 and FGFR2 (CD44v and FGFR2 IIIb, respectively) to the
mesenchymal-specific forms (CD44s and FGFR2 IIIc, respec-
tively) that are known to play a causative role in EMT (Warzecha
et al., 2009; Brown et al., 2011; Cieply and Carstens, 2015).
Although the log2 fold expression changes in the levels of the
alternatively spliced Cd44 and Fgfr2 cassettes in our differential
exon usage analysis of RNA-seq experiments did not reach
the stringent cutoff value that we initially established, their expres-
sion changes were statistically relevant (p.adj < 0.01). Figure 5B
shows that KHSRP overexpression significantly reduced the ratio972 Cell Reports 16, 967–978, July 26, 2016between the mesenchymal-type Cd44s and the epithelial-type
Cd44v isoform (Cd44s/Cd44v). Conversely, KHSRP knockdown
significantly enhanced the Cd44s/Cd44v ratio mimicking TGF-b
effect (Figure 5B). Similarly, KHSRP overexpression favored the
inclusion of the Fgfr2 epithelial-specific exon (IIIb), whereas
KHSRP silencing favored the inclusion of the mesenchymal
cassette (IIIc) in Fgfr2 mRNA (Figure 5C). Figure S5D shows that
KHSRP silencing induced a similar splicing pattern also in Py2T
cells. Furthermore, we showed that KHSRP re-expression in
NMuMg cells that achieved an established mesenchymal pheno-
type through a prolonged treatment with TGF-b (see Figures 3D
and S3H) reverts the TGF-b-induced mesenchymal pattern of
Cd44 splicing (Figure S5E). miR-27b-3p overexpression in un-
treated NMuMg cells mimicked both TGF-b effect and KHSRP
silencing by favoring mesenchymal-type splicing pattern of Cd44
pre-mRNA (Figure S5F, left). Conversely, miR-27b-3p silencing
prevented in part the TGF-b-mediated exclusion of variable
Cd44 exons (Figure S5F, right).
In order to identify the Enah, Cd44, and Fgfr2 pre-mRNA
regions bound by KHSRP, we probed anti-KHSRP RIP experi-
ments using intron-specific primers. A prominent KHSRP inter-
action with Enah intron 5-6, Cd44 intron 8-9, and Fgfr2 intron
5-6 was observed (Figure 5D; data not shown). The Cd44 region
spanning i8-9 includes a consensus binding motif for KHSRP
(identified on the basis of HITS-CLIP experiments) (D.B., G.B.
P.B., and R.G., unpublished data), and we proved the direct
interaction of recombinant KHSRP with this region by electro-
phoretic mobility shift assay (EMSA) (Figure S5G).
In order to support a direct regulation of CD44 alternative
splicing by KHSRP, we transiently expressed aminigene splicing
reporter construct including CD44 exon v8 and its flanking in-
trons in HEK293 cells. Figure S5H shows that KHSRP interacts
with the minigene in RIP experiments, and KHSRP knockdown
favored exon v8 skipping as evaluated by qRT-PCR using
specific primer sets that amplify exon CD44v8-included and
CD44v8-skipped products.
Altogether, our results indicate that KHSRP influences the
alternative splicing of a group of pre-mRNAs encoding factors
involved in cell-cell and cell-matrix interactions as well as in
cell migration.
KHSRP and hnRNPA1 Cooperate to Maintain the
Epithelial-type Pre-mRNA Splicing Pattern of Enah,
Cd44, and Fgfr2
Ribonucleoprotein complexes involvingmultiple regulatoryRBPs
able to modulate alternative splicing have recently emerged (see
Aparicio et al. [2013], Fu and Ares [2014], and Cieply and Cars-
tens [2015] for recent reviews).
We wanted to explore whether KHSRP associates with other
RBPs that are able to control alternative splicing events in
EMT. Epithelial splicing regulatory proteins 1 and 2 (ESRP1
and ESRP2, collectively indicated as ESRPs) are critical coordi-
nators of an epithelial cell-type-specific splicing program in
different cellular contexts (Warzecha et al., 2009; Bebee et al.,
2015). Indeed, KHSRP co-immunoprecipitates with ESRPs and
the proteins share similar pre-mRNA targets in 4T1 mammary
gland cells (Figures S6A and S6B; data not shown). However,
in NMuMg cells ESRP1 is not expressed while ESRP2 protein
Figure 5. KHSRP Controls Alternative Splicing of Enah, Cd44, and Fgfr2 Pre-mRNAs in NMuMg Cells
(A) Top: schematic of the exon-intron structure (not in scale) of EnahmRNA splice variants 201 and 004 (ENSMUSG00000022995). The green open boxmarks the
alternatively spliced exons 6 and 6L (in red), respectively. Bottom: qRT-PCR analysis performed using exon-specific primers. The results are presented as ratio
between the expression levels of Enah exon 6L-including and exon 6-including mRNA isoforms. NMuMg cells were infected with either control (AdNull) or
KHSRP-expressing adenoviral vectors (AdKHSRP) for 24 hr and subsequently serum-starved and either treated with TGF-b (+) for 24 hr or untreated () (left).
Either mock or shKHSRP NMuMg cells were serum-starved and then either treated with TGF-b or untreated for 24 hr (right).
(B) Top: schematic of the exon-intron structure (not in scale) of Cd44mRNA splice variants 001 and 002 (ENSMUSG00000005087). The red open box marks the
alternatively spliced variable exons. The bars mark the position of primers used to detect, by qRT-PCR, the expression levels of variable (V) and standard (S)
exons. Bottom: qRT-PCR analysis performed using the indicated primers. The results are presented as ratio between the expression levels of Cd44s and Cd44v
mRNA isoforms. NMuMg cells were cultured as described in (A).
(C) Top: schematic of the exon-intron structure (not in scale) of Fgfr2 mRNA splice variants 003 and 004 (ENSMUSG00000030849). The light blue and red open
boxes mark the region including exons IIIb (exon 6 in Fgfr2-003) and IIIc (exon 8 in Fgfr2-004), respectively. Bottom: qRT-PCR analysis performed using exon-
specific primers. The results are presented as ratio between the expression levels of exon IIIc- and exon IIIb- including mRNA isoforms. NMuMg cells were
cultured as described in (A). Arrows in the schematics indicate the transcription direction.
(D) Total extracts from NMuMg cells were immunoprecipitated as indicated. RNA was purified from immunocomplexes and analyzed by qRT-PCR to detect the
indicated pre-mRNAs.
The values of qRT-PCR experiments shown are averages ± SEM of three independent experiments performed in triplicate. Statistical significance: *p < 0.01,
**p < 0.001 (Student’s t test). See also Figure S5.is expressed at low levels and does not interact with KHSRP
(Figure 6B). Therefore, we explored the possibility that KHSRP
may associate with a different ribonucleoprotein complex in
NMuMg cells.
Some RBPs that have been implicated in splicing regulation
during EMT are either not expressed or do not interact with
KHSRP in NMuMg cells (data not shown; see the Discussion
below). The multifunctional RBP hnRNPA1 has been recently
implicated in cell-type-specific pre-mRNA splicing events (Bo-nomi et al., 2013; Douablin et al., 2015) and, interestingly,
whereas the expression of KHSRP and other alternative splicing
regulators is progressively silenced during EMT in NMuMg cells,
the levels of hnRNPA1 remain constant during cell exposure to
TGF-b (Figure 6A; data not shown). Co-immunoprecipitation ex-
periments revealed that KHSRP associates with hnRNPA1 and
that this interaction is abrogated by RNase A treatment (Fig-
ure 6B). This observation prompted us to explore whether
KHSRP and hnRNPA1 interact with the same pre-mRNA regionsCell Reports 16, 967–978, July 26, 2016 973
Figure 6. KHSRP and hnRNPA1 Cooperate
to Maintain the Epithelial-type Pre-mRNA
Splicing Pattern of Enah, Cd44, and Fgfr2
(A) Immunoblot analysis of total cell extracts from
NMuMg cells serum-starved and either treated
with TGF-b (+) for the indicated times or untreated
(). The indicated antibodies were used.
(B) Co-immunoprecipitation of hnRNPA1 and
KHSRP in total extracts from NMuMg cells. Cell
lysates either control-treated or treated with
RNase A (10 mg/ml for 30 min at 37C) were
immunoprecipitated as indicated and analyzed
by immunoblotting using the indicated anti-
bodies.
(C) qRT-PCR analysis of the indicated transcripts
in either control siRNA (siC) or sihnRNPA1-trans-
fected NMuMg cells.
(D) qRT-PCR analysis performed using primers
specific for the two isoforms of Enah, Cd44,
and Fgfr2 mRNAs, respectively. The results
are presented as ratio between the expres-
sion levels of the indicated mRNA isoforms.
NMuMg cells were transfected with either siC
or sihnRNPA1 and collected 48 hr after trans-
fection.
(E) Total extracts from either mock or shKHSRP
NMuMg cells were immunoprecipitated as indi-
cated. RNA was purified from immunocomplexes
and analyzed by qRT-PCR to detect the indicated
transcripts.
(F) Total extracts from NMuMg cells transfected
with either siC or sihnRNPA1 were immunopre-
cipitated as indicated. RNA was purified from
immunocomplexes and analyzed by qRT-PCR to
detect the indicated transcripts.
(G) Total extracts from shKHSRP NMuMg
cells, infected with either control (AdNull) or
KHSRP-expressing (AdKHSRP) adenoviral vec-
tors for 24 hr and subsequently serum-starved
and either treated with TGF-b (+) for 24 hr or un-
treated (), were immunoprecipitated as indi-
cated. RNA was purified from immunocomplexes
and analyzed by qRT-PCR to detect the indicated
transcript.
The position of molecular mass markers is indi-
cated on the left of each immunoblot. Representative gels are shown. The values of qRT-PCR experiments shown are averages ± SEM of three independent
experiments performed in triplicate. Statistical significance: *p < 0.01, **p < 0.001 (Student’s t test). See also Figure S6 and Table S1.of Enah, Cd44, and Fgfr2. RIP analysis results presented in Fig-
ure S6C indicate that this is the case. Further, EMSA experi-
ments revealed that recombinant hnRNPA1 directly interacts
with Cd44 (intron 8-9), the same region bound by recombinant
KHSRP (Figure S6D).
In order to investigate a possible role of hnRNPA1 in TGF-
b-dependent EMT, we transiently silenced hnRNPA1 in un-
treated NMuMg cells (Figure S6E) and found that its knockdown
enhances the expression of a subset of EMT factors (Figure 6C;
Table S1), whereas it does not affect miR-192-5p and miR-194-
5p expression (Figure S6F). Further, data presented in Figure 6D
shows that hnRNPA1 knockdown, similar to KHSRP silencing,
promoted the mesenchymal-type exon usage of Enah, Cd44,
and Fgfr2 pre-mRNA.
The interaction of hnRNPA1 with Enah, Cd44, and Fgfr2
pre-mRNAs is largely impaired by TGF-b treatment although974 Cell Reports 16, 967–978, July 26, 2016the protein continues to be expressed (see Figures 6A and
S6G; data not shown). Based on these findings, we investigated
whether KHSRP and hnRNPA1 mutually influence their binding
activity to Enah, Cd44, and Fgfr2 and pre-mRNAs. Although
either recombinant protein is able to bind a common target
RNA in vitro (Figures S5G and S6D), RIP analyses shown in Fig-
ures 6E and 6F indicate that the ability of hnRNPA1 to interact
with Enah, Cd44, and Fgfr2 pre-mRNAs is significantly impaired
by KHSRP knockdown, whereas the interaction of KHSRP with
the same pre-mRNAs is strongly reduced in hnRNPA1-knock-
down NMuMg cells. Finally, we showed that KHSRP re-expres-
sion in shKHSRP NMuMg cells was able to restore the ability of
hnRNPA1 to interact with Enah, Cd44, and Fgfr2 pre-mRNAs
(Figure 6G; data not shown; see also Figure S3H).
As a whole, our results suggest that KHSRP and hnRNPA1
are mutually necessary for binding to Enah, Cd44, and Fgfr2
Figure 7. Schematic Model Summarizing
the Mechanism by which TGF-b-Induced
KHSRP Silencing Contributes to EMT in
Mammary Gland NMuMg Cells
Black arrows indicate the steps of KHSRP-regu-
lated pathway. Red arrows indicate up- or down-
regulation of crucial events. The green arrow in-
dicates thematurationpathwayof primarymiR-192
maturation.pre-mRNAs and formaintaining the epithelial-type exon usage of
these transcripts in NMuMg cells.
DISCUSSION
Here, we report that TGF-b-dependent early induction of miR-
27b-3p silences KHSRP in non-transformed mammary gland
cells. This produces a vast rearrangement of the transcriptome
and contributes to EMT. KHSRP silencing impairs maturation
of miR-192-5p, with the consequent upregulation of a subset
of EMT factors, and favors alternative exon usage of genes
involved in cell adhesion and migration (a schematic of the
pathway is shown in Figure 7).
Our previous and current experiments suggest that ligands
belonging to the TGF-b family need to overcome KHSRP func-
tion in order to orient cell differentiation decisions. This is
achieved either through SMAD-mediated inhibition of KHSRP
activity that leads to a maturation blockade of pro-myogenic
miRNAs (Pasero et al., 2012) or through abrogation of KHSRP
expression as in the case of the present study. Here, we report
that miR-27b-3p is a component of the TGF-b signaling pathway
that contributes to development of the EMT process through
KHSRP silencing. AmiRNA-mediated downregulation of KHSRP
expression by TGF-b has also been reported by Sundaram et al.
(2013) showing that miR-181a-dependent KHSRP silencing
leads to a switch between primate-specific miR-198 maturation
and FSTL1 protein expression during wound healing. The fact
that in our model KHSRP silencing is achieved through a distinct
miRNA and results in a different cascade of events put forward
the idea that TGF-b family members operate in a variety of
ways to silence KHSRP expression/function and emphasizes
the importance of the ‘‘TGF-b/KHSRP antagonism’’ as a hub
during TGF-b-family-member-driven cell differentiation.
Although TGF-b-dependent KHSRP silencing controls the
expression of miRNAs previously implicated in EMT (Zhang
et al., 2014; data not shown), we decided to analyze in detail
the miR-192-5p function because its maturation from primary
transcripts is directly controlled by KHSRP. However, the evi-
dence that miR-192-5p silencing fails to reproduce the whole
spectrum of gene expression changes caused by KHSRPCsilencing, prompted us to explore the
impact of KHSRP on an additional layer
of regulation.
Despite the fact that biochemical
experiments uncovered KHSRP involve-
ment in alternative splicing almost 20
years ago (Min et al., 1997), we nowshow the role of KHSRP-modulated exon usage in a cell transdif-
ferentiation model. Regulation of gene expression by alternative
splicing was the first posttranscriptional mechanism linked to
EMT (Savagner et al., 1994) and, indeed, it can impact on all
the events described as ‘‘hallmarks of cancer.’’ RBPs able to
control alternative splicing have emerged as critical regulators
of EMT in the last few years. Huelga et al. (2012) demonstrated
on a genomic scale that RBPs coordinately regulate hundreds
of pre-mRNA alternative splicing events forming dynamically
regulated complexes. Here, we report on the interaction be-
tween KHSRP and ESRPs in cells that co-express the three pro-
teins. However, ESRP1 is not expressed while ESRP2 protein
levels are low in NMuMg cells (data not shown). Similarly,
Lin28, a factor recently reported as a modulator of alternative
splicing in breast cancer cells (Yang et al., 2015), is not ex-
pressed in NMuMg cells (data not shown). RNA helicases
DDX5 and DDX17 have been implicated at different transcrip-
tional and posttranscriptional levels in EMT and their expression
is silenced by TGF-b treatment (Dardenne et al., 2014). However,
their knockdown failed to affect the expression of EMT factors
and to influence the KHSRP-dependent alternative splicing
events in NMuMg cells (P.B. and R.G., unpublished observation).
Xu et al., (2014) have recently demonstrated that hnRNPM,
competing with ESRP1, favors the mesenchymal-type alterna-
tive splicing of CD44 and other pre-mRNAs and promotes breast
cancer metastasis by activating EMT. Also in this case, the fact
that ESRP1 is absent and hnRNPM expression is silenced in a
time-dependent manner in response to TGF-b in NMuMg cells
(data not shown) makes it unlikely that this regulatory network
is operative in our model. RBFOX2 is another important alterna-
tive splicing regulator in different tissues (Shapiro et al., 2011;
Braeutigam et al., 2014, Damianov et al., 2016). However, a com-
parison of RBFOX2 target transcripts described elsewhere
(Braeutigam et al., 2014) with the results of our analysis failed
to reveal any overlap.
hnRNPA1 has been implicated in a number of cellular pro-
cesses, including pre-mRNA splicing regulation (Matter et al.,
2000; He and Smith, 2009; Bonomi et al., 2013; Douablin
et al., 2015), and we and others have previously observed that
KHSRP and hnRNPA1 associate in different cell types (Ruggieroell Reports 16, 967–978, July 26, 2016 975
et al., 2007; Michlewski and Ca´ceres, 2010). Michlewski and
Ca´ceres (2010) demonstrated that the two proteins show
similar binding preferences to RNA sequences (Trabucchi
et al., 2009), and our in vitro binding data indicate that KHSRP
and hnRNPA1 directly bind to a region located in the intron 8-9
of Cd44 pre-mRNA. Interestingly, this sequence includes
two GGG triplets, a preferred binding site for both KHSRP
(Trabucchi et al., 2009), and hnRNPA1 (Michlewski and Ca´ceres,
2010). On the basis of our RIP analyses, it is tempting to
speculate that KHSRP and hnRNPA1 form a complex with
Enah, Cd44, and Fgfr2 pre-mRNAs, respectively, and each pro-
tein is required to allow the other to interact with these target
transcripts. TGF-b-induced KHSRP downregulation causes a
destabilization of the RNA-protein complex and hnRNPA1,
although still present, is unable to interact with Enah, Cd44,
and Fgfr2 pre-mRNAs.
Two recent reports suggested a major role for EMT in chemo-
resistance, and the analysis of our RNA-seq data showed that
KHSRP regulates the expression of a relevant number of tran-
scripts involved in drug transport and metabolism (Fischer
et al., 2015; Zheng et al., 2015) (Table S3). This allows us to hy-
pothesize that, in addition to affecting cell adhesion and migra-
tion, KHSRP could influence the expression of factors relevant
to other crucial EMT-driven events.
NMuMg cells used in our studies are representative of an
early stage of mammary transformation and respond to TGF-
b-inducing KHSRP silencing and, as a consequence, a variety of
EMT-like phenotypic changes. Inmore advanced stages of trans-
formation, cells become independent of TGF-b signaling and
KHSRP silencing fails to occur. This is in agreement with the evi-
dence that human tumors acquire loss-of-function mutations in
the genes encoding TGF-b receptors or SMAD proteins (Pardali
and Moustakas, 2007). We speculate that KHSRP silencing is
required in early stages of transformation in order to enable
TGF-b to initiate cell transdifferentiation process.Our contribution
to the understanding of how TGF-b-modulated KHSRP expres-
sion affects distinct layers of posttranscriptional gene control
provides insights in the biology of epithelial cells that are poised
to undergo a transition toward a mesenchymal phenotype.EXPERIMENTAL PROCEDURES
Cell Cultures and Treatments
Murine immortalized NMuMg cells (obtained from ATCC) were cultured in
DMEM plus 10% FBS and 10 mg/ml bovine insulin (Sigma-Aldrich). HEK293
cells (obtained from ATCC) were cultured in DMEM plus 10% FBS. Py2T cells,
a kind gift of Dr. G. Christofori (University of Basel), were cultured in DMEM
plus 10% FBS as described (Waldmeier et al., 2012). The immortalized
HMLE cells, a kind gift of Dr. R. Weinberg (Whitehead Institute), were cultured
as described (Elenbaas et al., 2001). Humanmammary gland adenocarcinoma
cells MDA-MB-231 and MCF7 were cultured in DMEM plus 5% FBS; human
non-tumorigenic epithelial cell line MCF 10A were cultured in DMEM/
F12 plus 5% horse serum, 10 mg/ml bovine insulin (Sigma-Aldrich), EGF
(20 ng/ml, Sigma-Aldrich), hydrocortisone (0.5 mg/ml, Sigma-Aldrich), and
cholera toxin (100 ng/ml, Sigma-Aldrich). 4T1 and TS/A mouse mammary
gland cancer cells (obtained from Dr. C. Bagni, VIB Center for the Biology of
Disease) were cultured in DMEM/F12 plus 10% FBS.
NMuMg and Py2T cells were maintained in DMEM supplemented with 2%
and 1% FBS, respectively, for 8–16 hr prior to the addition of 10 ng/ml human
recombinant TGF-b1 purchased from R&D Systems.976 Cell Reports 16, 967–978, July 26, 2016Phalloidin Staining
Mock and shKHSRP NMuMg cells were fixed in 3.7% formaldehyde, stained
using Alexa Fluor 568 Phalloidin, and imaged with the Imager M2 microscope
(Zeiss).
Scratch Wound Closure Assay
Cells were cultured in six-well plates up to sub-confluence and maintained in
2%FBS-containingmedium for 16 hr. After starvation, a woundwas scratched
into confluent monolayers, and cultures were either maintained in 2% FBS-
containing medium for 48 hr or treated with 10 ng/ml TGF-b in the same
medium for different times. Images were taken using a Olympus CKX41 mi-
croscope at different time post-wounding and analyzed using the ImageJ
package (http://imagej.nih.gov/ij/index.html). Average distance of wound ob-
tained from six microscopic fields was used for calculation of percent wound
healed. Experiments were performed three times.
Exon-Level Quantification and Splicing Analysis
To test differences in exon usage, we followed the procedure described for
DEXSeq (v 1.14.2, R 3.2.2) (Anders et al., 2012) adapting linear model design
to test for differential usage induced by TGF-b in the presence or absence of
KHSRP overexpression (cells infectedwith either AdKHSRP or AdNull, respec-
tively). IN brief, we first created a GFF file from the Ensembl GRCm38.74 GTF
with the provided script dexseq_prepare_annotation. Reads counts were then
collected from the sorted_by_name BAM, with dexseq_count.py on the
previously created GFF reference in ‘‘unstranded’’ ‘‘paired’’ mode. Exons
with log2 fold change greater than j1.2j (linear FC 2.3), showing an adjusted
p value <0.01 (FDR <1%, Benjamin-Hochberg corrected) were selected for
downstream analysis.
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